DADC
DPLO

D.A. Davidson & Co’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

D.A. Davidson & Co’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,417
Closed -$215K – 1200
2018
Q2 		$215K Buy
+8,417
New +$196K ﹤0.01% 1014
2018
Q1 		– Sell
-13,829
Closed -$278K – 1163
2017
Q4 		$278K Buy
+13,829
New +$272K 0.01% 880
2017
Q3 		– Sell
-6,563
Closed -$97K – 2213
2017
Q2 		$97K Buy
6,563
+144
+2% +$2.4K ﹤0.01% 1278
2017
Q1 		$102K Buy
6,419
+2,934
+84% +$42.3K ﹤0.01% 1245
2016
Q4 		$42K Sell
3,485
-5,400
-61% -$101K ﹤0.01% 1670
2016
Q3 		$247K Buy
8,885
+660
+8% +$22.1K 0.01% 862
2016
Q2 		$285K Buy
8,225
+2,178
+36% +$68.5K 0.01% 727
2016
Q1 		$163K Buy
6,047
+48
+0.8% +$1.41K 0.01% 924
2015
Q4 		$203K Buy
5,999
+1,059
+21% +$33K 0.01% 833
2015
Q3 		$141K Sell
4,940
-1,491
-23% -$63.8K ﹤0.01% 960
2015
Q2 		$287K Buy
+6,431
New +$242K 0.01% 734

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

D.A. Davidson & Co's DPLO Position: Q3 2018 in Review

D.A. Davidson & Co sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 8,417 shares — an estimated $215K sold.

D.A. Davidson & Co first reported a position in DPLO in Q2 2015 and held it in 11 quarters. The position peaked at $287K in Q2 2015. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • D.A. Davidson & Co reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • D.A. Davidson & Co sold 8,417 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $215K.
  • D.A. Davidson & Co first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 11 quarters.
  • D.A. Davidson & Co's DIPLOMAT PHARMACY, INC. position peaked at $287K in Q2 2015.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on D.A. Davidson & Co's 13F filing for Q3 2018, filed 13 Nov 2018.